DEFITELIO (Jazz Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the DEFITELIO drug offered from Jazz Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Jazz Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | defibrotide sodium |
| SUBSTANCE NAME: | DEFIBROTIDE SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-03-30 |
| END MARKETING DATE: | 0000-00-00 |
DEFITELIO HUMAN PRESCRIPTION DRUG Details:
| Item Description | DEFITELIO from Jazz Pharmaceuticals, Inc. |
| LABELER NAME: | Jazz Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 80(mg/mL) |
| START MARKETING DATE: | 2016-03-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68727-800_c64466c2-3e9e-4470-96b7-0b25c3f0648f |
| PRODUCT NDC: | 68727-800 |
| APPLICATION NUMBER: | NDA208114 |
Other DEFIBROTIDE SODIUM Pharmaceutical Manufacturers / Labelers:
